{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T14:12:00Z","timestamp":1779372720782,"version":"3.53.1"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Dysphagia is a potentially fatal symptom of Parkinson\u2019s disease (PD) and is characterized by frequent silent aspiration, a risk factor for aspiration pneumonia. The transdermal dopamine agonist rotigotine alleviates dysphagia in patients with PD and is more effective than oral levodopa, suggesting the importance of continuous dopaminergic stimulation (CDS) in swallowing. Safinamide is a monoamine oxidase B (MAOB) inhibitor that facilitates CDS. In this retrospective open-label evaluator-blinded research, swallowing functions in nine patients with PD were examined using a video fluoroscopic swallowing study (VFSS) before and after treatment with 50 mg of oral safinamide. The VFSS results showed that safinamide significantly improved some swallowing measures during oral and pharyngeal phases, including oral transit time and pharyngeal transit time, without worsening of any measures. Notably, improvements in lip closure, an oral phase component, seemed to be most attributable to improvements in oral phase scores. In conclusion, a medicine for CDS may effectively improve swallowing functions in patients with PD. This is the first study to show that the MAOB inhibitor safinamide partly but significantly improves swallowing function in patients with PD.<\/jats:p>","DOI":"10.1371\/journal.pone.0286066","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T17:27:30Z","timestamp":1685035650000},"page":"e0286066","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["The effects of safinamide on dysphagia in Parkinson\u2019s disease"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0759-1627","authenticated-orcid":true,"given":"Makito","family":"Hirano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Samukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiharu","family":"Isono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1037-3129","authenticated-orcid":true,"given":"Yoshitaka","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"issue":"5","key":"pone.0286066.ref001","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1378\/chest.14-0066","article-title":"Decreased cough sensitivity and aspiration in Parkinson disease","volume":"146","author":"MS Troche","year":"2014","journal-title":"Chest"},{"issue":"2","key":"pone.0286066.ref002","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archneur.58.2.259","article-title":"Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders","volume":"58","author":"J Muller","year":"2001","journal-title":"Arch Neurol"},{"issue":"Suppl 2","key":"pone.0286066.ref003","first-page":"60","article-title":"Prognosis of Parkinson\u2019s disease in Japan. Tottori University Parkinson\u2019s Disease Epidemiology (TUPDE) Study Group","volume":"38","author":"K Nakashima","year":"1997","journal-title":"Eur Neurol"},{"issue":"6","key":"pone.0286066.ref004","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/mds.870110622","article-title":"Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson\u2019s disease","volume":"11","author":"F Tison","year":"1996","journal-title":"Mov Disord"},{"issue":"7","key":"pone.0286066.ref005","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/NEN.0b013e3182965886","article-title":"Parkinson disease affects peripheral sensory nerves in the pharynx","volume":"72","author":"L Mu","year":"2013","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"pone.0286066.ref006","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.parkreldis.2012.11.017","article-title":"Swallowing improvement after levodopa treatment in idiopathic Parkinson\u2019s disease: lack of evidence","volume":"19","author":"A Melo","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"pone.0286066.ref007","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1044\/2021_AJSLP-21-00145","article-title":"Effectiveness of Interventions for Dysphagia in Parkinson Disease: A Systematic Review","volume":"31","author":"P Gandhi","year":"2022","journal-title":"Am J Speech Lang Pathol"},{"issue":"5","key":"pone.0286066.ref008","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/jnnp.63.5.579","article-title":"Response of parkinsonian swallowing dysfunction to dopaminergic stimulation","volume":"63","author":"PC Hunter","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"pone.0286066.ref009","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2019.07.003","article-title":"Effects of the rotigotine transdermal patch versus oral levodopa on swallowing in patients with Parkinson\u2019s disease","volume":"404","author":"M Hirano","year":"2019","journal-title":"J Neurol Sci"},{"issue":"4","key":"pone.0286066.ref010","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00455-015-9622-5","article-title":"Rotigotine Transdermal Patch Improves Swallowing in Dysphagic Patients with Parkinson\u2019s Disease","volume":"30","author":"M Hirano","year":"2015","journal-title":"Dysphagia"},{"issue":"4","key":"pone.0286066.ref011","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2147\/nedt.2006.2.4.421","article-title":"Rotigotine transdermal system: a short review","volume":"2","author":"S Bunten","year":"2006","journal-title":"Neuropsychiatr Dis Treat"},{"key":"pone.0286066.ref012","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.parkreldis.2020.07.010","article-title":"Rasagiline monotherapy improves swallowing in patients with Parkinson\u2019s disease","volume":"78","author":"M Hirano","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"pone.0286066.ref013","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.parkreldis.2020.04.012","article-title":"Efficacy and safety of safinamide as an add-on therapy to L-DOPA for patients with Parkinson\u2019s disease: A randomized, double-blind, placebo-controlled, phase II\/III study","volume":"75","author":"N Hattori","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"pone.0286066.ref014","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/jamaneurol.2016.4467","article-title":"Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial","volume":"74","author":"AH Schapira","year":"2017","journal-title":"JAMA Neurol"},{"key":"pone.0286066.ref015","volume-title":"Evaluation and Treatment of Swallowing Disorders","author":"JA Longemann","year":"1983"},{"issue":"3","key":"pone.0286066.ref016","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/PL00009595","article-title":"The Dysphagia Outcome and Severity Scale","volume":"14","author":"KH O\u2019Neil","year":"1999","journal-title":"Dysphagia"},{"issue":"2","key":"pone.0286066.ref017","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00455-016-9758-y","article-title":"Development of International Terminology and Definitions for Texture-Modified Foods and Thickened Fluids Used in Dysphagia Management: The IDDSI Framework","volume":"32","author":"JA Cichero","year":"2017","journal-title":"Dysphagia"},{"issue":"8","key":"pone.0286066.ref018","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s00405-004-0883-0","article-title":"Swallowing function in patients with multiple-system atrophy with a clinical predominance of cerebellar symptoms (MSA-C)","volume":"262","author":"R Higo","year":"2005","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"3","key":"pone.0286066.ref019","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00455-013-9450-4","article-title":"Differences in dysphagia between spinocerebellar ataxia type 3 and type 6","volume":"28","author":"C Isono","year":"2013","journal-title":"Dysphagia"},{"key":"pone.0286066.ref020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"issue":"6","key":"pone.0286066.ref021","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.21037\/jtd.2017.05.34","article-title":"A general introduction to adjustment for multiple comparisons","volume":"9","author":"SY Chen","year":"2017","journal-title":"J Thorac Dis"},{"issue":"3","key":"pone.0286066.ref022","doi-asserted-by":"crossref","first-page":"e0194536","DOI":"10.1371\/journal.pone.0194536","article-title":"MDR1 gene polymorphisms are associated with ulcerative colitis in a cohort of Serbian patients with inflammatory bowel disease","volume":"13","author":"D Mijac","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"pone.0286066.ref023","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2019EZR\u2019 for medical statistics","volume":"48","author":"Y. Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"pone.0286066.ref024","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1007\/s00784-021-04359-9","article-title":"Oral health-related quality of life (OHRQOL) of preschool children\u2019s anterior teeth restored with zirconia crowns versus resin-bonded composite strip crowns: a 12-month prospective clinical trial","volume":"26","author":"AAH Elheeny","year":"2022","journal-title":"Clin Oral Investig"},{"issue":"3","key":"pone.0286066.ref025","doi-asserted-by":"crossref","first-page":"e0173157","DOI":"10.1371\/journal.pone.0173157","article-title":"Validity and reliability of a new tool to evaluate handwriting difficulties in Parkinson\u2019s disease","volume":"12","author":"E Nackaerts","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"pone.0286066.ref026","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12883-021-02105-y","article-title":"Facial tremor in patients with Parkinson\u2019s disease: prevalence, determinants and impacts on disease progression","volume":"21","author":"R Ou","year":"2021","journal-title":"BMC Neurol"},{"issue":"7 Suppl 2","key":"pone.0286066.ref027","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1212\/WNL.67.7_suppl_2.S18","article-title":"Safinamide: from molecular targets to a new anti-Parkinson drug","volume":"67","author":"C Caccia","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"pone.0286066.ref028","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","article-title":"Animal models of Parkinson\u2019s disease: a source of novel treatments and clues to the cause of the disease","volume":"164","author":"S Duty","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"9","key":"pone.0286066.ref029","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.parkreldis.2014.06.016","article-title":"Off and on state assessment of swallowing function in Parkinson\u2019s disease","volume":"20","author":"T Warnecke","year":"2014","journal-title":"Parkinsonism Relat Disord"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0286066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T03:38:44Z","timestamp":1729481924000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0286066"}},"subtitle":[],"editor":[{"given":"Keisuke","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0286066","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,25]]}}}